| Mrs Elizabeth Katherine Durham, DO | |
|
350 Hospital Way, Suite 101, Somerset, KY 42503 | |
| (606) 451-5092 | |
| Not Available |
| Full Name | Mrs Elizabeth Katherine Durham |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 350 Hospital Way, Somerset, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518312339 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lake Cumberland Regional Hospital | Somerset, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeastern Emergency Physicians Llc | 2466364997 | 491 |
News Archive
Canadian researchers have pinpointed a new gene associated with peanut allergy, offering further evidence that genes play a role in the development of food allergies and opening the door to future research, improved diagnostics and new treatment options.
"Three" kinds of regalia such as crown, orb, and sward are often necessary to be a high king for conquering the world. For fighting off cancerous diseases, what do we need? This "triple" chemical modified nanomaterial might be save the patient.
Gilead Sciences, Inc. announced today that its Marketing Authorisation Application (MAA) for elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced patients, has been validated by the European Medicines Agency (EMA).
Curis, Inc., an oncology focused company developing novel, targeted drug candidates for the treatment of human cancers, and Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology as well as companion diagnostics, today announced presentation of data for Debio 0932 at the Annual Meeting of the American Association for Cancer Research (AACR) that demonstrated synergy between Debio 0932 and various standard of care (SOC) agents in multiple in vitro and xenograft models of non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC).
› Verified 7 days ago
| Entity Name | Southeastern Emergency Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356379382 PECOS PAC ID: 2466364997 Enrollment ID: O20050302000285 |
News Archive
Canadian researchers have pinpointed a new gene associated with peanut allergy, offering further evidence that genes play a role in the development of food allergies and opening the door to future research, improved diagnostics and new treatment options.
"Three" kinds of regalia such as crown, orb, and sward are often necessary to be a high king for conquering the world. For fighting off cancerous diseases, what do we need? This "triple" chemical modified nanomaterial might be save the patient.
Gilead Sciences, Inc. announced today that its Marketing Authorisation Application (MAA) for elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced patients, has been validated by the European Medicines Agency (EMA).
Curis, Inc., an oncology focused company developing novel, targeted drug candidates for the treatment of human cancers, and Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology as well as companion diagnostics, today announced presentation of data for Debio 0932 at the Annual Meeting of the American Association for Cancer Research (AACR) that demonstrated synergy between Debio 0932 and various standard of care (SOC) agents in multiple in vitro and xenograft models of non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Elizabeth Katherine Durham, DO 350 Hospital Way, Suite 101, Somerset, KY 42503-2872 Ph: (606) 451-5092 | Mrs Elizabeth Katherine Durham, DO 350 Hospital Way, Suite 101, Somerset, KY 42503 Ph: (606) 451-5092 |
News Archive
Canadian researchers have pinpointed a new gene associated with peanut allergy, offering further evidence that genes play a role in the development of food allergies and opening the door to future research, improved diagnostics and new treatment options.
"Three" kinds of regalia such as crown, orb, and sward are often necessary to be a high king for conquering the world. For fighting off cancerous diseases, what do we need? This "triple" chemical modified nanomaterial might be save the patient.
Gilead Sciences, Inc. announced today that its Marketing Authorisation Application (MAA) for elvitegravir, an integrase inhibitor for the treatment of HIV-1 infection in treatment-experienced patients, has been validated by the European Medicines Agency (EMA).
Curis, Inc., an oncology focused company developing novel, targeted drug candidates for the treatment of human cancers, and Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology as well as companion diagnostics, today announced presentation of data for Debio 0932 at the Annual Meeting of the American Association for Cancer Research (AACR) that demonstrated synergy between Debio 0932 and various standard of care (SOC) agents in multiple in vitro and xenograft models of non-small cell lung cancer (NSCLC) and renal cell carcinoma (RCC).
› Verified 7 days ago
Mr. Rainer Allen Oliver, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Hospital Way, Suite 101, Somerset, KY 42503 Phone: 606-451-5093 Fax: 606-451-5087 | |
Lyndsey King, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 Langdon St, Somerset, KY 42503 Phone: 606-679-7441 | |
Umar Bhatti, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Hospital Way, Somerset, KY 42503 Phone: 606-451-5093 | |
Dr. Kevin A Hinson, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 350 Hospital Way Ste 101, Somerset, KY 42503 Phone: 606-451-5093 | |
Dr. Curtis Anthony Williams, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 Langdon St, Somerset, KY 42503 Phone: 606-451-2601 | |
Dr. Bernard Williams, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 Langdon St, Somerset, KY 42503 Phone: 606-679-7441 |